DS
David Schenkein
Internal Medicine
Credentials: · · ·
History
Internal Medicine
Research
A phase 2 study of bortezomib in relapsed, refractory myeloma
New England Journal of Medicine · 2003 · 2,206 citations
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
New England Journal of Medicine · 2005 · 2,069 citations
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation
Science · 2013 · 687 citations
- KM
25 papers
11 papers
10 papers
- DI
8 papers
- JB
8 papers
7 papers
- BB
6 papers
- ET
6 papers
Grants
- 1998–2001
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $85.5K · Tufts Medical Center
- 1990–1995
Early Events in Retroviral Replication
National Cancer Institute · K08
Contact PI · $398K · Tufts Medical Center